miR-212 acts as a tumor suppressor, and its aberrant expression participates in the augmentation of a cell proliferation phenotype through induction of impaired RBP2 expression and downregulation of P21CIP1/P27kip1 [149, 150]. Here, CDKN1A is linked to neoplasm.